BMH BRÄUTIGAM advises Earlybird on € 3.2 million financing round of Nosh.bio
BMH BRÄUTIGAM has advised Earlybird Venture Capital on the € 3.2 million seed financing round of Berlin-based food tech startup Nosh.bio.
Nosh.bio was founded in 2022 by Tim Fronzek, formerly co-founder of rebuy.com, and Felipe Lino, former Novozymes researcher and global R&D manager at AB-InBev, with the goal of helping to shape the food industry of tomorrow. The company uses natural, fermented mycoprotein to put highly functional, healthy and clean-label ingredients on the market at the same price as animal-based ingredients. Nosh.bio's ingredients have binding, gelling and texturizing properties and are expected to replace chemical additives in the future, enabling, for example, the production of meat substitutes with a single ingredient. In addition to lead investor Earlybird Venture Capital, U.S. fund Clear Current Capital, Grey Silo Ventures and Good Seed Ventures participated in the round. With the fresh capital, Nosh.bio will continue to commercialize its first product, develop R&D processes and expand production capacity. Background: BMH BRÄUTIGAM continuously advises Earlybird on investments (most recently on the Greenlyte financing round, among others) and was able to further strengthen and expand the client relationship. Team BMH BRÄUTIGAM: Bastian Reinschmidt, Dr. Jan Böhle, Lisa-Marie Sarucco (all Venture Capital)